The United States preclinical medical device testing services market is poised for substantial growth in the coming decade, reflecting the increasing demand for regulatory compliance, technological advancements, and patient safety initiatives. Valued at USD 1,696.0 million in 2025, the market is projected to expand at a compound annual growth rate (CAGR) of 5.3%, reaching approximately …